Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors-Reference-Cited by-同舟云学术

Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors

Published:2020-09-22 Issue:1 Volume:26 Page:186-191
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Altan Mesut^ORCID,Haberal Hakan Bahadır,Aşçı Ahmet,Güdeloğlu Ahmet,Doğrul Ahmet Bülent,Yazıcı Mustafa Sertaç,Akdoğan Bülent,Özen Haluk

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-020-01786-8.pdf

Reference23 articles.

1. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8:1777–1781

2. van Dijk MR, Steyerberg EW, Habbema JD (2006) Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis. Eur J Cancer 42:820–826

3. Spiess PE, Brown GA, Liu P et al (2006) Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer 107:1483–1490

4. Hendry WF, Norman AR, Dearnaley DP et al (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94:1668–1676

5. de Wit R, Stoter G, Kaye SB et al (1997) Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group. J Clin Oncol 15:1837–1843